Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1987 Feb;84(4):1112–1116. doi: 10.1073/pnas.84.4.1112

Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone.

J I Paz-Bouza, T W Redding, A V Schally
PMCID: PMC304372  PMID: 2881296

Abstract

Pancreatic ductal adenocarcinoma was induced in female Syrian golden hamsters by injecting N-nitrosobis(2-oxopropyl)amine (BOP) once a week at a dose of 10 mg per kg of body weight for 18 weeks. Hamsters were then treated with somatostatin analog D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH2 (RC-160) or with [6-D-tryptophan]luteinizing hormone-releasing hormone [( D-Trp6]LH-RH) delayed delivery systems. Microcapsules of somatostatin analog RC-160, designed to release a dose of 5 micrograms/day, were injected twice a month and microcapsules of [D-Trp6]LH-RH, calculated to liberate 25 micrograms per day, once a month. After 18 weeks of BOP administration, the hamsters were divided into three groups of 10-20 animals each. Group I consisted of untreated controls, group II was injected with RC-160, and group III was injected with [D-Trp6]LH-RH. A striking decrease in tumor weight and volume was obtained in animals treated with [D-Trp6]LH-RH or with the somatostatin analog RC-160. After 45 days of treatment with either analog, the survival rate was significantly higher in groups II and III (70%), as compared with the control group (35%). The studies, done by light microscopy, high-resolution microscopy, and electron microscopy, showed a decrease in the total number of cancer cells and changes in the epithelium, connective tissue, and cellular organelles in groups II and III treated with the hypothalamic analogs as compared to controls. These results in female hamsters with induced ductal pancreatic tumors confirm and extend our findings, obtained in male animals with transplanted tumors, that [D-Trp6]LH-RH and somatostatin analogs inhibit the growth of pancreatic cancers.

Full text

PDF
1112

Images in this article

1114Image
on p.1114
1114Image
on p.1114
1114Image
on p.1114
1115Image
on p.1115
1115Image
on p.1115
1115Image
on p.1115
1115Image
on p.1115

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Althoff J., Pour P., Malick L., Wilson R. B. Pancreatic neoplasms induced in Syrian golden hamsters. I. Scanning electron microscopic observations. Am J Pathol. 1976 Jun;83(3):517–530. [PMC free article] [PubMed] [Google Scholar]
  2. Althoff J., Wilson R. B., Ogrowsky D., Pour P. The fine structure of pancreatic duct neoplasm in Syrian golden hamsters. Prog Exp Tumor Res. 1979;24:397–405. doi: 10.1159/000402114. [DOI] [PubMed] [Google Scholar]
  3. Cai R. Z., Szoke B., Lu R., Fu D., Redding T. W., Schally A. V. Synthesis and biological activity of highly potent octapeptide analogs of somatostatin. Proc Natl Acad Sci U S A. 1986 Mar;83(6):1896–1900. doi: 10.1073/pnas.83.6.1896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dembinski A. B., Johnson L. R. Stimulation of pancreatic growth by secretin, caerulein, and pentagastrin. Endocrinology. 1980 Jan;106(1):323–328. doi: 10.1210/endo-106-1-323. [DOI] [PubMed] [Google Scholar]
  5. Fenoglio C. M., King D. W. Somatostatin: an update. Hum Pathol. 1983 Jun;14(6):475–479. doi: 10.1016/s0046-8177(83)80001-x. [DOI] [PubMed] [Google Scholar]
  6. Flaks A., Moore M. A., Flaks B. Ultrastructural analysis of pancreatic carcinogenesis. II. Establishment and morphology of a transplantable hamster pancreatic adenocarcinoma, FCP. Carcinogenesis. 1980 Jun;1(6):513–522. doi: 10.1093/carcin/1.6.513. [DOI] [PubMed] [Google Scholar]
  7. Flaks B., Moore M. A., Flaks A. Ultrastructural analysis of pancreatic carcinogenesis. V. Changes in differentiation of acinar cells during chronic treatment with N-nitrosobis(2-hydroxypropyl)amine. Carcinogenesis. 1982;3(5):485–498. doi: 10.1093/carcin/3.5.485. [DOI] [PubMed] [Google Scholar]
  8. Flaks B., Moore M. A., Flaks A. Ultrastructural analysis of pancreatic carcinogenesis: morphological characterization of N-nitroso-bis(2-hydroxypropyl)amine-induced neoplasms in the Syrian hamster. Carcinogenesis. 1980 May;1(5):423–438. doi: 10.1093/carcin/1.5.423. [DOI] [PubMed] [Google Scholar]
  9. Gonzalez-Barcena D., Rangel-Garcia N. E., Perez-Sanchez P. L., Gutierrez-Damperio C., Garcia-Carrasco F., Comaru-Schally A. M., Schally A. V. Response to D-Trp-6-LH-RH in advanced adenocarcinoma of pancreas. Lancet. 1986 Jul 19;2(8499):154–154. doi: 10.1016/s0140-6736(86)91961-6. [DOI] [PubMed] [Google Scholar]
  10. Greenway B., Iqbal M. J., Johnson P. J., Williams R. Oestrogen receptor proteins in malignant and fetal pancreas. Br Med J (Clin Res Ed) 1981 Sep 19;283(6294):751–753. doi: 10.1136/bmj.283.6294.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hierowski M. T., Liebow C., du Sapin K., Schally A. V. Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA PaCa-2 cell line. FEBS Lett. 1985 Jan 7;179(2):252–256. doi: 10.1016/0014-5793(85)80529-9. [DOI] [PubMed] [Google Scholar]
  12. Johnson L. R. Effects of gastrointestinal hormones on pancreatic growth. Cancer. 1981 Mar 15;47(6 Suppl):1640–1645. doi: 10.1002/1097-0142(19810315)47:6+<1640::aid-cncr2820471430>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  13. Longnecker D. S., Curphey T. J. Adenocarcinoma of the pancreas in azaserine-treated rats. Cancer Res. 1975 Aug;35(8):2249–2258. [PubMed] [Google Scholar]
  14. Longnecker D. S., Roebuck B. D., Kuhlmann E. T., Curphey T. J. Induction of pancreatic carcinomas in rats with N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine: histopathology. J Natl Cancer Inst. 1985 Jan;74(1):209–217. [PubMed] [Google Scholar]
  15. Longnecker D. S., Roebuck B. D., Yager J. D., Jr, Lilja H. S., Siegmund B. Pancreatic carcinoma in azaserine-treated rats: induction, classification and dietary modulation of incidence. Cancer. 1981 Mar 15;47(6 Suppl):1562–1572. doi: 10.1002/1097-0142(19810315)47:6+<1562::aid-cncr2820471419>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  16. Mascardo R. N., Sherline P. Somatostatin inhibits rapid centrosomal separation and cell proliferation induced by epidermal growth factor. Endocrinology. 1982 Oct;111(4):1394–1396. doi: 10.1210/endo-111-4-1394. [DOI] [PubMed] [Google Scholar]
  17. Ogrowsky D., Fawcett J., Althoff J., Wilson R. B., Pour P. Structure of the pancreas in Syrian hamsters. Scanning electron-microscopic observations. Acta Anat (Basel) 1980;107(2):121–128. doi: 10.1159/000145236. [DOI] [PubMed] [Google Scholar]
  18. Petersen H., Solomon T., Grossman M. I. Effect of chronic pentagastrin, cholecystokinin, and secretin on pancreas of rats. Am J Physiol. 1978 Mar;234(3):E286–E293. doi: 10.1152/ajpendo.1978.234.3.E286. [DOI] [PubMed] [Google Scholar]
  19. Pour P. M. Induction of unusual pancreatic neoplasms, with morphologic similarity to human tumors, and evidence for their ductal/ductular cell origin. Cancer. 1985 May 15;55(10):2411–2416. doi: 10.1002/1097-0142(19850515)55:10<2411::aid-cncr2820551019>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  20. Redding T. W., Schally A. V. Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones. Proc Natl Acad Sci U S A. 1984 Jan;81(1):248–252. doi: 10.1073/pnas.81.1.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Roebuck B. D., Lilja H. S., Curphey T. J., Longnecker D. S. Pathologic and biochemical effects of azaserine in inbred Wistar/Lewis rats and noninbred CD-1 mice. J Natl Cancer Inst. 1980 Aug;65(2):383–389. [PubMed] [Google Scholar]
  22. Schally A. V., Comaru-Schally A. M., Redding T. W. Antitumor effects of analogs of hypothalamic hormones in endocrine-dependent cancers. Proc Soc Exp Biol Med. 1984 Mar;175(3):259–281. doi: 10.3181/00379727-175-41797. [DOI] [PubMed] [Google Scholar]
  23. Schally A. V., Kook A. I., Monje E., Redding T. W., Paz-Bouza J. I. Combination of a long-acting delivery system for luteinizing hormone-releasing hormone agonist with Novantrone chemotherapy: increased efficacy in the rat prostate cancer model. Proc Natl Acad Sci U S A. 1986 Nov;83(22):8764–8768. doi: 10.1073/pnas.83.22.8764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Theve N. O., Pousette A., Carlström K. Adenocarcinoma of the pancreas--a hormone sensitive tumor? A preliminary report on Nolvadex treatment. Clin Oncol. 1983 Sep;9(3):193–197. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES